BML-190
≈ 1 min read
Names in other languages
No names in other languages are held for this entry yet.
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
BML-190, also known as indomethacin morpholinylamide, is a drug used in scientific research that acts as a selective CB 2 inverse agonist. BML-190 is structurally derived from the NSAID indomethacin but has a quite different biological activity. The activity produced by this compound is disputed, with some sources referring to it as a CB 2 agonist rather than an inverse agonist; this may reflect an error in classification, or alternatively it may produce different effects in different tissues, and more research is required to resolve this dispute.
BML-190, also known as indomethacin morpholinylamide, is a drug used in scientific research that acts as a selective CB 2 inverse agonist. BML-190 is structurally derived from the NSAID indomethacin but has a quite different biological activity. The activity produced by this compound is disputed, with some sources referring to it as a CB 2 agonist rather than an inverse agonist; this may reflect an error in classification, or alternatively it may produce different effects in different tissues, and more research is required to resolve this dispute.
See also
Substituted tryptamine
References
Text derived from https://en.wikipedia.org/w/index.php?oldid=1341436414 under CC BY-SA 4.0; modifications have been made.